Table 2.
Hyperglycemic Marker | Metabolic Indices | |
---|---|---|
Latino (n=206) [83••]b | 6–6.4% vs. <6.0% | 21%
SI 30% Insulin Secretion 31% DI |
5.7–6.4% vs. <5.7% | ≈ SI ≈ AIR ≈ DI |
|
Caucasian & AA (n=204) [84••]c | 5.7–6.4% vs. <5.7% | 18%
SI 30% GDI |
| ||
Caucasian & AA (n=223) [87•]c | ≥90–99 mg/dL vs. <90 mg/dL fasting | ≈ SI Insulin Secretion 23% GDId |
Caucasian & AA (n=113) [88]c | ≥155 mg/dL vs. <155 mg/dL at 1-hr post OGTT | ≈ SI ≈ Insulin Secretion 35.5% GDId |
Caucasian (n=1,454) [90] | ≥132 mg/dL vs. <132 mg/dL at 1-hr post OGTT | DIe |
Latino (n=233, 9-yr longitudinal) [89••]b | ≥155 mg/dL vs. <155 mg/dL at 1hr post OGTT | ≈ SI Insulin Secretion DI |
Caucasian & AA (n=147) [91]a,c | ≥120 mg/dL vs. <120 mg/dL at 2-hr post OGTT | ≈ SI ≈ Insulin Secretion 40% GDId |
Caucasian, non-diabetic (n=60, 2-yr longitudinal) [92••]c | 120–139 mg/dL vs. 100–199 vs. <100 mg/dL at 2-hr post OGTT |
SI Insulin Secretion |
Study included non-diabetic and diabetic children;
Studies used FSIVGTT with minimal modeling (Disposition index [DI] = insulin sensitivity [SI] * acute insulin response [AIR]);
Studies compared hepatic and peripheral insulin sensitivity by [6,6-2H2] glucose and a 3-h hyperinsulinemic-euglycemic clamp and β-cell function by a 2-h hyperglycemic clamp (~225 mg/dL).
Glucose disposition index (GDI) was expressed relative to insulin sensitivity (GDI = SI * first-phase insulin).
DI was calculated from a regression equation using data from an OGTT.